Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

The prognostic impact of cirrhosis on patients receiving maintenance haemodialysis.

Artru F, Louvet A, Glowacki F, Bellati S, Frimat M, Gomis S, Castel H, Barthelon J, Lassailly G, Dharancy S, Noel C, Hazzan M, Mathurin P.

Aliment Pharmacol Ther. 2019 Jul;50(1):75-83. doi: 10.1111/apt.15279. Epub 2019 May 14.

PMID:
31087566
2.

Risk Factors for Early Graft Failure and Death After Kidney Transplantation in Recipients Older Than 70 Years.

Lemoine M, Titeca Beauport D, Lobbedez T, Choukroun G, Hurault de Ligny B, Hazzan M, Guerrot D, Bertrand D.

Kidney Int Rep. 2019 Jan 28;4(5):656-666. doi: 10.1016/j.ekir.2019.01.014. eCollection 2019 May.

3.

Epitope load identifies kidney transplant recipients at risk of allosensitization following minimization of immunosuppression.

Snanoudj R, Kamar N, Cassuto E, Caillard S, Metzger M, Merville P, Thierry A, Jollet I, Grimbert P, Anglicheau D, Hazzan M, Choukroun G, Hurault De Ligny B, Janbon B, Vuiblet V, Devys A, Le Meur Y, Delahousse M, Morelon E, Bailly E, Girerd S, Amokrane K, Legendre C, Hertig A, Rondeau E, Taupin JL.

Kidney Int. 2019 Jun;95(6):1471-1485. doi: 10.1016/j.kint.2018.12.029. Epub 2019 Mar 5.

PMID:
30955869
4.

Transplant center characteristics associated with living-donor kidney transplantation: a cohort study with a hierarchical modeling approach.

Châtelet V, Gatault P, Hazzan M, Anglicheau D, Launoy G, Lobbedez T, Moulin B.

Transpl Int. 2019 Mar 22. doi: 10.1111/tri.13429. [Epub ahead of print]

PMID:
30903630
5.

Control of replication of hepatitis B and C virus improves patient and graft survival in kidney transplantation.

Fontaine H, Alric L, Labreuche J, Legendre B, Louvet A, Antoine C, Legendre CM, Hazzan M, Kamar N, Dharancy S, Pol S, Duhamel A, Mathurin P.

J Hepatol. 2019 May;70(5):831-838. doi: 10.1016/j.jhep.2018.12.036. Epub 2019 Mar 14.

PMID:
30879789
6.

Evaluation of outcomes in renal transplantation with hypothermic machine perfusion for the preservation of kidneys from expanded criteria donors.

Savoye E, Macher MA, Videcoq M, Gatault P, Hazzan M, Abboud I, Thierry A, Bertrand D, Drouin S, Sayegh J, Barrou B, Badet L, Bastien O, Huot O, Lamotte C, Logerot H, Legeai C, Antoine C.

Clin Transplant. 2019 May;33(5):e13536. doi: 10.1111/ctr.13536. Epub 2019 Apr 10.

PMID:
30869162
7.

Early Acute Microvascular Kidney Transplant Rejection in the Absence of Anti-HLA Antibodies Is Associated with Preformed IgG Antibodies against Diverse Glomerular Endothelial Cell Antigens.

Delville M, Lamarthée B, Pagie S, See SB, Rabant M, Burger C, Gatault P, Giral M, Thaunat O, Arzouk N, Hertig A, Hazzan M, Matignon M, Mariat C, Caillard S, Kamar N, Sayegh J, Westeel PF, Garrouste C, Ladrière M, Vuiblet V, Rivalan J, Merville P, Bertrand D, Le Moine A, Van Huyen JPD, Cesbron A, Cagnard N, Alibeu O, Satchell SC, Legendre C, Zorn E, Taupin JL, Charreau B, Anglicheau D.

J Am Soc Nephrol. 2019 Apr;30(4):692-709. doi: 10.1681/ASN.2018080868. Epub 2019 Mar 8.

PMID:
30850439
8.

Heme Drives Susceptibility of Glomerular Endothelium to Complement Overactivation Due to Inefficient Upregulation of Heme Oxygenase-1.

May O, Merle NS, Grunenwald A, Gnemmi V, Leon J, Payet C, Robe-Rybkine T, Paule R, Delguste F, Satchell SC, Mathieson PW, Hazzan M, Boulanger E, Dimitrov JD, Fremeaux-Bacchi V, Frimat M, Roumenina LT.

Front Immunol. 2018 Dec 20;9:3008. doi: 10.3389/fimmu.2018.03008. eCollection 2018.

9.

[Human resources allocated to kidney transplantation in 2016 in France: A national survey].

Gatault P, Hazzan M, Anglicheau D, Moulin B; Commission transplantation de la SFNDT.

Nephrol Ther. 2018 Nov;14(6):491-498. doi: 10.1016/j.nephro.2018.06.002. Epub 2018 Aug 25. French.

PMID:
30154055
10.

Improving the Supply and Quality of Deceased-Donor Organs for Transplantation.

Maanaoui M, Hazzan M, Provôt F.

N Engl J Med. 2018 Aug 16;379(7):692. doi: 10.1056/NEJMc1808003. No abstract available.

PMID:
30124265
11.

Review: Management of patients with kidney allograft failure.

Bunthof KLW, Hazzan M, Hilbrands LB.

Transplant Rev (Orlando). 2018 Jul;32(3):178-186. doi: 10.1016/j.trre.2018.03.001. Epub 2018 Mar 29. Review.

PMID:
29628415
12.

Changes in bone mineral density after kidney transplantation: 2-year assessment of a French cohort.

Segaud N, Legroux I, Hazzan M, Noel C, Cortet B.

Osteoporos Int. 2018 May;29(5):1165-1175. doi: 10.1007/s00198-018-4383-2. Epub 2018 Mar 2.

PMID:
29500526
13.

[Clinical pharmacist and medication reconciliation in kidney transplantation].

Flamme-Obry F, Belaiche S, Hazzan M, Ramdan N, Noël C, Odou P, Décaudin B.

Nephrol Ther. 2018 Apr;14(2):91-98. doi: 10.1016/j.nephro.2017.04.004. Epub 2018 Feb 22. French.

PMID:
29477279
14.

Outcome of autosomal dominant polycystic kidney disease patients on peritoneal dialysis: a national retrospective study based on two French registries (the French Language Peritoneal Dialysis Registry and the French Renal Epidemiology and Information Network).

Sigogne M, Kanagaratnam L, Dupont V, Couchoud C, Verger C, Maheut H, Hazzan M, Halimi JM, Barbe C, Canivet E, Petrache A, Dramé M, Rieu P, Touré F.

Nephrol Dial Transplant. 2018 Nov 1;33(11):2020-2026. doi: 10.1093/ndt/gfx364.

PMID:
29361078
15.

[Vancomycin poisoning successfully treated with intermittent hemodialysis: A case report].

Zaworski J, Frimat M, Duval M, Saint-Jacques C, Bouderlique É, Glowacki F, Noël C, Hazzan M, Provôt F.

Nephrol Ther. 2018 Apr;14(2):112-116. doi: 10.1016/j.nephro.2017.10.004. Epub 2017 Dec 30. French.

PMID:
29295766
16.

Factors associated with the variability of calcineurin inhibitor blood levels in kidney recipients grafted for more than 1 year.

Belaiche S, Décaudin B, Dharancy S, Gautier S, Noel C, Odou P, Hazzan M.

Fundam Clin Pharmacol. 2018 Feb;32(1):88-97. doi: 10.1111/fcp.12328. Epub 2017 Nov 10.

PMID:
29069531
17.

Glomerulonephritis and granulomatous vasculitis in kidney as a complication of the use of BRAF and MEK inhibitors in the treatment of metastatic melanoma: A case report.

Maanaoui M, Saint-Jacques C, Gnemmi V, Frimat M, Lionet A, Hazzan M, Noël C, Provot F.

Medicine (Baltimore). 2017 Jun;96(25):e7196. doi: 10.1097/MD.0000000000007196.

18.

Risk factors for Pneumocystis pneumonia after the first 6 months following renal transplantation.

Faure E, Lionet A, Kipnis E, Noël C, Hazzan M.

Transpl Infect Dis. 2017 Oct;19(5). doi: 10.1111/tid.12735. Epub 2017 Jul 28.

PMID:
28608641
19.

[New scores in renal transplantation: How can we use them?]

Hazzan M, Frimat M, Glowacki F, Lionet A, Provot F, Noël C.

Nephrol Ther. 2017 Apr;13 Suppl 1:S131-S136. doi: 10.1016/j.nephro.2017.01.005. French.

PMID:
28577735
20.

Factors relevant to medication non-adherence in kidney transplant: a systematic review.

Belaiche S, Décaudin B, Dharancy S, Noel C, Odou P, Hazzan M.

Int J Clin Pharm. 2017 Jun;39(3):582-593. doi: 10.1007/s11096-017-0436-4. Epub 2017 Apr 3. Review.

PMID:
28374343
21.

Kidney transplantation in patients with systemic sclerosis: a nationwide multicentre study.

Bertrand D, Dehay J, Ott J, Sberro R, Brunelle C, Kamar N, Colosio C, Chatelet V, Albano L, Girerd S, Audard V, Barbet C, Dantal J, Ducloux D, Durrbach A, Garrigue V, Hazzan M, Heng AE, Mariat C, Merville P, Rerolle JP, Moulin B, Guerrot D.

Transpl Int. 2017 Mar;30(3):256-265. doi: 10.1111/tri.12923.

22.

Post-transplantation diabetes: Treatment à la carte?

Benomar K, Espiard S, Vahe C, Le Mapihan K, Jannin A, Dharancy S, Hazzan M, Vantyghem MC.

Diabetes Metab. 2017 Sep;43(4):378-381. doi: 10.1016/j.diabet.2016.09.011. Epub 2016 Nov 10. Review. No abstract available.

PMID:
27840114
23.

Long-term outcome after early cyclosporine withdrawal in kidney transplantation: ten years after.

Tabibzadeh N, Glowacki F, Frimat M, Elsermans V, Provôt F, Lionet A, Gnemmi V, Hertig A, Noël C, Hazzan M.

Clin Transplant. 2016 Nov;30(11):1480-1487. doi: 10.1111/ctr.12843. Epub 2016 Oct 13.

PMID:
27623348
24.

Immunosuppression in the elderly renal allograft recipient: a systematic review.

Montero N, Pérez-Sáez MJ, Pascual J; DESCARTES Working Group; DESCARTES ERA-EDTA Board:, Abramowicz D, Budde K, Dudley C, Hazzan M, Klinger M, Maggiore U, Oberbauer R, Pascual J, Sorensen SS, Viklicky O.

Transplant Rev (Orlando). 2016 Jul;30(3):144-53. doi: 10.1016/j.trre.2016.05.001. Epub 2016 May 20. Review.

PMID:
27279024
25.

The DESCARTES-Nantes survey of kidney transplant recipients displaying clinical operational tolerance identifies 35 new tolerant patients and 34 almost tolerant patients.

Massart A, Pallier A, Pascual J, Viklicky O, Budde K, Spasovski G, Klinger M, Sever MS, Sørensen SS, Hadaya K, Oberbauer R, Dudley C, De Fijter JW, Yussim A, Hazzan M, Wekerle T, Berglund D, De Biase C, Pérez-Sáez MJ, Mühlfeld A, Orlando G, Clemente K, Lai Q, Pisani F, Kandus A, Baas M, Bemelman F, Ponikvar JB, Mazouz H, Stratta P, Subra JF, Villemain F, Hoitsma A, Braun L, Cantarell MC, Colak H, Courtney A, Frasca GM, Howse M, Naesens M, Reischig T, Serón D, Seyahi N, Tugmen C, Alonso Hernandez A, Beňa L, Biancone L, Cuna V, Díaz-Corte C, Dufay A, Gaasbeek A, Garnier A, Gatault P, Gentil Govantes MA, Glowacki F, Gross O, Hurault de Ligny B, Huynh-Do U, Janbon B, Jiménez Del Cerro LA, Keller F, La Manna G, Lauzurica R, Le Monies De Sagazan H, Thaiss F, Legendre C, Martin S, Moal MC, Noël C, Pillebout E, Piredda GB, Puga AR, Sulowicz W, Tuglular S, Prokopova M, Chesneau M, Le Moine A, Guérif P, Soulillou JP, Abramowicz M, Giral M, Racapé J, Maggiore U, Brouard S, Abramowicz D.

Nephrol Dial Transplant. 2016 Jun;31(6):1002-13. doi: 10.1093/ndt/gfv437. Epub 2016 Jan 12.

PMID:
26763669
26.

Does pre-emptive transplantation versus post start of dialysis transplantation with a kidney from a living donor improve outcomes after transplantation? A systematic literature review and position statement by the Descartes Working Group and ERBP.

Abramowicz D, Hazzan M, Maggiore U, Peruzzi L, Cochat P, Oberbauer R, Haller MC, Van Biesen W; Descartes Working Group and the European Renal Best Practice (ERBP) Advisory Board.

Nephrol Dial Transplant. 2016 May;31(5):691-7. doi: 10.1093/ndt/gfv378. Epub 2015 Nov 12. Review.

PMID:
26567249
27.

Calcineurin Inhibitors Downregulate HNF-1β and May Affect the Outcome of HNF1B Patients After Renal Transplantation.

Faguer S, Esposito L, Casemayou A, Pirson Y, Decramer S, Cartery C, Hazzan M, Garrigue V, Roussey G, Cointault O, Ho T, Merville P, Devuyst O, Gourdy P, Chassaing N, Bascands JL, Kamar N, Schanstra JP, Rostaing L, Chauveau D.

Transplantation. 2016 Sep;100(9):1970-8. doi: 10.1097/TP.0000000000000993.

28.

One-year Results of the Effects of Rituximab on Acute Antibody-Mediated Rejection in Renal Transplantation: RITUX ERAH, a Multicenter Double-blind Randomized Placebo-controlled Trial.

Sautenet B, Blancho G, Büchler M, Morelon E, Toupance O, Barrou B, Ducloux D, Chatelet V, Moulin B, Freguin C, Hazzan M, Lang P, Legendre C, Merville P, Mourad G, Mousson C, Pouteil-Noble C, Purgus R, Rerolle JP, Sayegh J, Westeel PF, Zaoui P, Boivin H, Le Gouge A, Lebranchu Y.

Transplantation. 2016 Feb;100(2):391-9. doi: 10.1097/TP.0000000000000958.

PMID:
26555944
29.

Access to preemptive registration on the waiting list for renal transplantation: a hierarchical modeling approach.

Riffaut N, Lobbedez T, Hazzan M, Bertrand D, Westeel PF, Launoy G, Danneville I, Bouvier N, Hurault de Ligny B.

Transpl Int. 2015 Sep;28(9):1066-73. doi: 10.1111/tri.12592. Epub 2015 Apr 28.

30.

Fibrosis progression according to epithelial-mesenchymal transition profile: a randomized trial of everolimus versus CsA.

Rostaing L, Hertig A, Albano L, Anglicheau D, Durrbach A, Vuiblet V, Moulin B, Merville P, Hazzan M, Lang P, Touchard G, Hurault deLigny B, Quéré S, Di Giambattista F, Dubois YC, Rondeau E; CERTITEM Study Group.

Am J Transplant. 2015 May;15(5):1303-12. doi: 10.1111/ajt.13132. Epub 2015 Mar 23.

31.

Daclizumab Versus Rabbit Antithymocyte Globulin in High-Risk Renal Transplants: Five-Year Follow-up of a Randomized Study.

Hellemans R, Hazzan M, Durand D, Mourad G, Lang P, Kessler M, Charpentier B, Touchard G, Berthoux F, Merville P, Ouali N, Squifflet JP, Bayle F, Wissing KM, Noël C, Abramowicz D.

Am J Transplant. 2015 Jul;15(7):1923-32. doi: 10.1111/ajt.13191. Epub 2015 Feb 23.

32.

Donor ABCB1 genetic polymorphisms influence epithelial-to-mesenchyme transition in tacrolimus-treated kidney recipients.

Bloch J, Hazzan M, Van der Hauwaert C, Buob D, Savary G, Hertig A, Gnemmi V, Frimat M, Perrais M, Copin MC, Broly F, Noël C, Pottier N, Cauffiez C, Glowacki F.

Pharmacogenomics. 2014 Dec;15(16):2011-24. doi: 10.2217/pgs.14.146.

PMID:
25521359
33.

Mother-requested cesarean delivery compared to vaginal delivery: a systematic review.

Bernardo LS, Simões R, Bernardo WM, Toledo SF, Hazzan MA, Chan HF, Bucci KB, Mercuri G.

Rev Assoc Med Bras (1992). 2014 Jul;60(4):302-4. Review. No abstract available.

34.

Strategies to increase the donor pool and access to kidney transplantation: an international perspective.

Maggiore U, Oberbauer R, Pascual J, Viklicky O, Dudley C, Budde K, Sorensen SS, Hazzan M, Klinger M, Abramowicz D; ERA-EDTA-DESCARTES Working Group.

Nephrol Dial Transplant. 2015 Feb;30(2):217-22. doi: 10.1093/ndt/gfu212. Epub 2014 Jun 6. Review.

35.

Treating diabetes with islet transplantation: lessons from the past decade in Lille.

Vantyghem MC, Defrance F, Quintin D, Leroy C, Raverdi V, Prévost G, Caiazzo R, Kerr-Conte J, Glowacki F, Hazzan M, Noel C, Pattou F, Diamenord AS, Bresson R, Bourdelle-Hego MF, Cazaubiel M, Cordonnier M, Delefosse D, Dorey F, Fayard A, Fermon C, Fontaine P, Gillot C, Haye S, Le Guillou AC, Karrouz W, Lemaire C, Lepeut M, Leroy R, Mycinski B, Parent E, Siame C, Sterkers A, Torres F, Verier-Mine O, Verlet E; G4 working groups, Desailloud R, Dürrbach A, Godin M, Lalau JD, Lukas-Croisier C, Thervet E, Toupance O, Reznik Y, Westeel PF.

Diabetes Metab. 2014 Apr;40(2):108-19. doi: 10.1016/j.diabet.2013.10.003. Epub 2014 Feb 6. Review.

PMID:
24507950
36.

Increased circulating miR-21 levels are associated with kidney fibrosis.

Glowacki F, Savary G, Gnemmi V, Buob D, Van der Hauwaert C, Lo-Guidice JM, Bouyé S, Hazzan M, Pottier N, Perrais M, Aubert S, Cauffiez C.

PLoS One. 2013;8(2):e58014. doi: 10.1371/journal.pone.0058014. Epub 2013 Feb 28.

37.

Continuous glucose monitoring after islet transplantation in type 1 diabetes: an excellent graft function (β-score greater than 7) Is required to abrogate hyperglycemia, whereas a minimal function is necessary to suppress severe hypoglycemia (β-score greater than 3).

Vantyghem MC, Raverdy V, Balavoine AS, Defrance F, Caiazzo R, Arnalsteen L, Gmyr V, Hazzan M, Noël C, Kerr-Conte J, Pattou F.

J Clin Endocrinol Metab. 2012 Nov;97(11):E2078-83. doi: 10.1210/jc.2012-2115. Epub 2012 Sep 20.

38.

Renal involvement in MELAS syndrome - a series of 5 cases and review of the literature.

Seidowsky A, Hoffmann M, Glowacki F, Dhaenens CM, Devaux JP, de Sainte Foy CL, Provot F, Gheerbrant JD, Hummel A, Hazzan M, Dracon M, Dieux-Coeslier A, Copin MC, Noël C, Buob D.

Clin Nephrol. 2013 Dec;80(6):456-63. doi: 10.5414/CN107063. Review.

PMID:
22909780
39.

Three-year outcome of isolated glomerulitis on 3-month protocol biopsies of donor HLA antibody negative patients.

Buob D, Grimbert P, Glowacki F, Labalette M, Dufossé F, Nochy D, Copin MC, Boleslawski E, Noël C, Hazzan M.

Transpl Int. 2012 Jun;25(6):663-70. doi: 10.1111/j.1432-2277.2012.01473.x. Epub 2012 Apr 5.

40.

Chemical interesterification of blends of palm stearin, coconut oil, and canola oil: physicochemical properties.

Soares FA, da Silva RC, Hazzan M, Capacla IR, Viccola ER, Maruyama JM, Gioielli LA.

J Agric Food Chem. 2012 Feb 15;60(6):1461-9. doi: 10.1021/jf204111t. Epub 2012 Feb 6.

PMID:
22229347
41.

Epithelial-to-mesenchymal transition predicts cyclosporine nephrotoxicity in renal transplant recipients.

Hazzan M, Hertig A, Buob D, Copin MC, Noël C, Rondeau E, Dubois-Xu YC.

J Am Soc Nephrol. 2011 Jul;22(7):1375-81. doi: 10.1681/ASN.2010060673. Epub 2011 Jun 30.

42.

Anti-viral therapy in haemodialysed HCV patients: efficacy, tolerance and treatment strategy.

Deltenre P, Moreno C, Tran A, Ollivier I, Provôt F, Stanke F, Lazrek M, Castel H, Canva V, Louvet A, Colin M, Glowacki F, Dharancy S, Henrion J, Hazzan M, Noel C, Mathurin P.

Aliment Pharmacol Ther. 2011 Aug;34(4):454-61. doi: 10.1111/j.1365-2036.2011.04741.x. Epub 2011 Jun 20.

43.

CYP3A5 and ABCB1 polymorphisms in donor and recipient: impact on Tacrolimus dose requirements and clinical outcome after renal transplantation.

Glowacki F, Lionet A, Buob D, Labalette M, Allorge D, Provôt F, Hazzan M, Noël C, Broly F, Cauffiez C.

Nephrol Dial Transplant. 2011 Sep;26(9):3046-50. doi: 10.1093/ndt/gfr253. Epub 2011 Jun 15.

PMID:
21677300
44.

[How far to promote renal transplantation from living kidney donors?].

Martin PY, Hazzan M.

Nephrol Ther. 2011 Dec;7(7):519-20. doi: 10.1016/j.nephro.2011.04.003. Epub 2011 May 19. French. No abstract available.

PMID:
21600863
45.

Influence of cytochrome P450 3A5 (CYP3A5) genetic polymorphism on the pharmacokinetics of the prolonged-release, once-daily formulation of tacrolimus in stable renal transplant recipients.

Glowacki F, Lionet A, Hammelin JP, Labalette M, Provôt F, Hazzan M, Broly F, Noël C, Cauffiez C.

Clin Pharmacokinet. 2011 Jul;50(7):451-9. doi: 10.2165/11587050-000000000-00000.

PMID:
21528942
46.

An exceptional minute tumour incidentally found in a renal biopsy.

Buob D, Copin MC, Perez T, Hachulla E, Hazzan M, Leroy X.

Nephrol Dial Transplant. 2011 Apr;26(4):1436-8. doi: 10.1093/ndt/gfq836. Epub 2011 Feb 15.

PMID:
21324975
47.

[Nephrology and therapeutics. Editorial].

Frimat L, Hazzan M.

Nephrol Ther. 2011 Feb;7(1):1. doi: 10.1016/j.nephro.2011.01.004. French. No abstract available.

PMID:
21295746
48.

NK cell regulation of CD4 T cell-mediated graft-versus-host disease.

Noval Rivas M, Hazzan M, Weatherly K, Gaudray F, Salmon I, Braun MY.

J Immunol. 2010 Jun 15;184(12):6790-8. doi: 10.4049/jimmunol.0902598. Epub 2010 May 19.

49.

[Weaning from corticosteroid therapy after kidney transplantation].

Hazzan M, Glowacki F, Lionet A, Provôt F, Noël C.

Nephrol Ther. 2009 Dec;5 Suppl 6:S355-8. doi: 10.1016/S1769-7255(09)73425-X. French.

PMID:
20129445
50.

[Minimize kidney failure in transplantation patients with proliferation signal inhibitors].

Glowacki F, Dharancy S, Noël C, Hazzan M.

Gastroenterol Clin Biol. 2009 Nov;33 Suppl 4:S253-6. doi: 10.1016/S0399-8320(09)73162-8. French.

Supplemental Content

Loading ...
Support Center